Biomarin Pharmaceutical (BMRN) Q3 2026 Earnings

4AugConfirmed
Q3 2025
Q4 2025
Q2 2026
Next
-0.28
0.22
0.73
1.23

Details

Expected EPS
0.953108
Actual EPS
N/A
Surprise EPS
-0.95
Surprise Percent
+100%

Description

Biomarin Pharmaceutical (BMRN) will report earnings of for Q3 2026 on August 04, 2026.

0 Comments

Share your thoughts